Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.

Autor:in

Kupisiewicz, Katarzyna; Boissy, Patrice; Abdallah, Basem M; Hansen, Frederik Dagnaes; Erben, Reinhold G; Savouret, Jean-Francois; Søe, Kent; Andersen, Thomas L; Plesner, Torben; Delaisse, Jean-Marie;

Schlagwörter

Animals; Anticarcinogenic Agents/agonists; Anticarcinogenic Agents/therapeutic use; Bone Density Conservation Agents/agonists; Bone Density Conservation Agents/therapeutic use; Cell Line, Tumor; Female; Growth Inhibitors/agonists*; Growth Inhibitors/therapeutic use; Humans; Osteoblasts/cytology; Osteoblasts/drug effects*; Osteoclasts/cytology; Osteoclasts/drug effects*; Osteogenesis/drug effects*; Osteogenesis/physiology; Osteoporosis/drug therapy*; Osteoporosis/metabolism; Osteoporosis/physiopathology; Rats; Stilbenes/agonists*; Stilbenes/therapeutic use; Treatment Outcome;

ISSN/eISSN

0171-967X -

WoS ID

WOS:000283558500008